Director Zachary Prensky to retire from LB Pharmaceuticals board at 2026 annual meeting

LB PHARMACEUTICALS INC

Zachary Prensky notified board on March 13, 2026; will not stand for reelection at the 2026 annual meeting.
Prensky remains on board and Nominating & Governance Committee until the meeting concludes.
Decision was not due to any disagreement with the company; he will provide consulting services post-retirement.
Amendment to Transition Agreement allows unvested stock options to continue vesting during the consulting term.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.